These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3875310)

  • 61. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
    Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
    Parker RH; Eggleston M
    Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.
    Hyslop DL; Jacobson K; Guerra FJ
    Clin Ther; 1992; 14(2):254-67. PubMed ID: 1611648
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic diversity of the ftsI gene in β-lactamase-nonproducing ampicillin-resistant and β-lactamase-producing amoxicillin-/clavulanic acid-resistant nasopharyngeal Haemophilus influenzae strains isolated from children in South Korea.
    Park C; Kim KH; Shin NY; Byun JH; Kwon EY; Lee JW; Kwon HJ; Choi EY; Lee DG; Sohn WY; Kang JH
    Microb Drug Resist; 2013 Jun; 19(3):224-30. PubMed ID: 23308379
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment failure in Haemophilus influenzae due to a beta-lactamase low-level ampicillin-resistant organism.
    van der Ploeg V; Gelinck LB; Jonkers IJ; Mourer JS; van Dam AP
    J Infect; 2008 Dec; 57(6):485-8. PubMed ID: 18775568
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cefpodoxime proxetil in the treatment of lower respiratory tract infections.
    Geddes AM
    Drugs; 1991; 42 Suppl 3():34-40. PubMed ID: 1726206
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.
    Piot P; Van Dyck E
    Antimicrob Agents Chemother; 1982 Jan; 21(1):166-7. PubMed ID: 6805422
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.
    Jorgensen JH; Doern GV; Maher LA; Howell AW; Redding JS
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2075-80. PubMed ID: 2127342
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro and in vivo synergism between amoxicillin and clavulanic acid against ampicillin-resistant Haemophilus influenzae type b.
    Yogev R; Melick C; Kabat WJ
    Antimicrob Agents Chemother; 1981 Jun; 19(6):993-6. PubMed ID: 6973952
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antimicrobial susceptibility of Haemophilus influenzae strains and antibiotics usage patterns in pediatric outpatients: results from a children's hospital in China (2000-2004).
    Wang A; Yu S; Yao K; Zhang W; Yuan L; Wang Y; Wei J; Shen X; Yang Y
    Pediatr Pulmonol; 2008 May; 43(5):457-62. PubMed ID: 18360841
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative study of cephradine and amoxicillin-clavulanate in the treatment of recurrent urinary tract infections.
    Brumfitt W; Hamilton-Miller JM
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1803-5. PubMed ID: 2285294
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
    Thornsberry C; Ogilvie P; Kahn J; Mauriz Y
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):249-57. PubMed ID: 9458982
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Therapy of chronic recurrent respiratory tract infections].
    Nagatake T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):289-92. PubMed ID: 2615085
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):647-9. PubMed ID: 4093205
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recurrent and penicillin V-resistant otitis media. A treatment study with amoxycillin/clavulanate and cefaclor.
    Jacobsson S; Rignér P; von Sydow C; Bondesson G
    Acta Otolaryngol; 1988; 106(3-4):171-7. PubMed ID: 3140574
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative.
    Jones ME; Karlowsky JA; Blosser-Middleton R; Critchley IA; Thornsberry C; Sahm DF
    Int J Antimicrob Agents; 2002 Feb; 19(2):119-23. PubMed ID: 11850164
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.
    Steingrube VA; Wallace RJ; Brown BA; Pang Y; Zeluff B; Steele LC; Zhang Y
    Antimicrob Agents Chemother; 1991 Mar; 35(3):524-8. PubMed ID: 2039203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.